These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 21400753)

  • 21. Long-term adefovir dipivoxil monotherapy for up to 5 years in lamivudine-resistant chronic hepatitis B.
    Lee JM; Park JY; Kim DY; Nguyen T; Hong SP; Kim SO; Chon CY; Han KH; Ahn SH
    Antivir Ther; 2010; 15(2):235-41. PubMed ID: 20386079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of thymosine 1 alpha and Lamivudine combination therapy in chronic hepatitis B patients.
    Dikici B; Bosnak M; Haspolat K
    Indian Pediatr; 2002 Jul; 39(7):701-2. PubMed ID: 12147907
    [No Abstract]   [Full Text] [Related]  

  • 23. Early detection of viral resistance by determination of hepatitis B virus polymerase mutations in patients treated by lamivudine for chronic hepatitis B.
    Nafa S; Ahmed S; Tavan D; Pichoud C; Berby F; Stuyver L; Johnson M; Merle P; Abidi H; Trépo C; Zoulim F
    Hepatology; 2000 Nov; 32(5):1078-88. PubMed ID: 11050059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cycloferon in treating duodenal ulcers in rats].
    Bul'on VV; Khnychenko LK; Sapronov NS; Kuznetsova NN; Anikin VB; arinenko RIu; Kovalenko AL; Alekseeva LE
    Eksp Klin Farmakol; 2001; 64(6):41-4. PubMed ID: 11871237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of long-term lamivudine in chronic hepatitis B virus-infected children.
    Ozgenç F; Arikan C; Sertoz RY; Nart D; Aydogdu S; Yagci RV
    Antivir Ther; 2004 Oct; 9(5):729-32. PubMed ID: 15535410
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical efficiency of reamberin - cycloferon combination in treatment of hepatic cirrhosis associated with chronic HCV infection].
    Frolov VM; Sotskaia IaA; Kruglova OV
    Eksp Klin Farmakol; 2012; 75(8):34-8. PubMed ID: 23012994
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overlap lamivudine treatment in patients with chronic hepatitis B receiving adefovir for lamivudine-resistant viral mutants.
    Liu CJ; Kao JH; Chen PJ; Chen TC; Lin FY; Lai MY; Chen DS
    J Viral Hepat; 2006 Jun; 13(6):387-95. PubMed ID: 16842441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treating chronic lamivudine-resistant hepatitis B in HIV co-infected patients].
    Benhamou Y
    Gastroenterol Clin Biol; 2006 Oct; 30(10 Pt 2):3S22-5. PubMed ID: 17075492
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment of chlamydial infection in chronic prostatitis].
    Shperling NV; Vengerovskiĭ AI; Shperling IA; Mironiuk DV; Bezmenova MA; Kalaĭda EV
    Urologiia; 2011; (4):45, 47-9. PubMed ID: 22066242
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Short-term lamivudine for the treatment of chronic hepatitis B.
    Yotsuyanagi H; Yasuda K; Iino S
    Intervirology; 2003; 46(6):367-72. PubMed ID: 14688454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical course of patients with chronic hepatitis B with viral breakthrough during long-term lamivudine treatment.
    Ide T; Kumashiro R; Kuwahara R; Koga H; Koga Y; Hino T; Tanaka K; Hisamochi A; Ogata K; Sata M;
    J Gastroenterol; 2005 Jun; 40(6):625-30. PubMed ID: 16007397
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interferon-lamivudine combination is no better than lamivudine alone in anti-HBe-positive chronic hepatitis B.
    Akarca US; Ersoz G; Gunsar F; Karasu Z; Saritas E; Yuce G; Batur Y
    Antivir Ther; 2004 Jun; 9(3):325-34. PubMed ID: 15259895
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Entecavir is superior to lamivudine in reducing hepatitis B virus DNA in patients with chronic hepatitis B infection.
    Lai CL; Rosmawati M; Lao J; Van Vlierberghe H; Anderson FH; Thomas N; Dehertogh D
    Gastroenterology; 2002 Dec; 123(6):1831-8. PubMed ID: 12454840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Response to long-term lamivudine treatment in patients infected with hepatitis B virus genotypes A, B, and C.
    Kobayashi M; Suzuki F; Akuta N; Suzuki Y; Arase Y; Ikeda K; Hosaka T; Sezaki H; Kobayashi M; Iwasaki S; Sato J; Watahiki S; Miyakawa Y; Kumada H
    J Med Virol; 2006 Oct; 78(10):1276-83. PubMed ID: 16927289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lamivudine-resistant chronic hepatitis B: an observational study on adefovir in monotherapy or in combination with lamivudine.
    Gaia S; Barbon V; Smedile A; Olivero A; Carenzi S; Lagget M; Alessandria C; Rizzetto M; Marzano A
    J Hepatol; 2008 Apr; 48(4):540-7. PubMed ID: 18279995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cycloferon--a new domestic preparation for the prophylaxis of influenza and other acute respiratory viral infections].
    Ershov FI; Kovalenko AL; Garashchenko TI; Sel'kova EP; Botvin'eva VV; Zhekalov AN; Petlenko SV; Bol'bot IuK; Romantsov MG
    Zh Mikrobiol Epidemiol Immunobiol; 2004; (6):47-51. PubMed ID: 15636140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Favorable efficacy of long-term lamivudine therapy in patients with chronic hepatitis B: an 8-year follow-up study.
    Akuta N; Suzuki F; Suzuki Y; Sezaki H; Hosaka T; Someya T; Kobayashi M; Saitoh S; Arase Y; Ikeda K; Kobayashi M; Kumada H
    J Med Virol; 2005 Apr; 75(4):491-8. PubMed ID: 15714490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lamivudine treatment for chronic hepatitis B infection in children unresponsive to interferon.
    Hartman C; Berkowitz D; Shouval D; Eshach-Adiv O; Hino B; Rimon N; Satinger I; Kra-Oz T; Daudi N; Shamir R
    Pediatr Infect Dis J; 2003 Mar; 22(3):224-9. PubMed ID: 12634582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical potential of emerging new agents in hepatitis B.
    Farrell GC
    Drugs; 2000 Oct; 60(4):701-10. PubMed ID: 11085196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Lamivudine treatment for hepatitis B].
    Lamivudine Clincal Practice Group
    Zhonghua Gan Zang Bing Za Zhi; 2004 Jul; 12(7):425-8. PubMed ID: 15487066
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.